Skip to content

Ryan D Ward

9 papers in the library · 11 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Personalised Perception: The Effect of Personality on the Sensory Effects of Psychedelics.

Drug and Alcohol Review July 1, 2026 Alexander Boardman, Jai Whelan, Ryan D Ward

INTRODUCTION: Psychedelics induce a wide range of sensory distortions and hallucinations (henceforth 'distortions'). Yet, little is known about factors that influence the occurrence of certain distortions. Extra-pharmacological variables including personality traits have been found to correlate with the occurrence of different subjective features during the acute psychedelic state. The current...

Ketamine-Assisted Psychotherapy for Addiction: Mechanisms, Evidence, and Clinical Implications

April 1, 2025 Ryan D Ward

Substance use disorders (SUDs) are notoriously difficult to treat due to complex biopsychosocial underpinnings and high relapse rates. Recent evidence positions ketamine-assisted psychotherapy (KAP) as a promising intervention for treatment-resistant addiction. This review explores ketamine’s neurobiological mechanisms, its synergistic effect with psychotherapy, and clinical data supporting its...

Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand.

Journal of Psychoactive Drugs March 5, 2025 Ethan Mills, Jai Whelan, Sarah Mcgruddy et al. 3 citations

While interest in psychedelic research has recently increased globally, little is known about use in Aotearoa New Zealand. Therefore, we sought to explore motivations, features of subjective experience, and impact of use. We also aimed to explore and compare positive, typical, and worst experiences. An online survey was completed by 997 individuals who had used at least one classical...

DOI: 10.1080/02791072.2025.2474236 (opens in new tab) Full text (opens in new tab) Aotearoa new zealand Psychedelic Experience Impact +1

The psychedelic mind: Current user perceptions of psychedelic drugs and their use

Drugs, Habits and Social Policy July 18, 2024 Sarah Mcgruddy, Jai Whelan, Ethan Mills et al.

Purpose Psychedelic drugs can induce altered states of consciousness characterised by changes in visual perception, tactile sensation, cognition, and emotion. Although there is a history of misinformation surrounding these drugs, recent investigation has reinvigorated interest. However, little research has assessed the attitudes of psychedelic consumers regarding these substances. The current...

A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand.

Harm Reduction Journal May 23, 2024 Jai Whelan, Ryan D Ward, Geoff Noller 2 citations

Methylenedioxymethamphetamine (MDMA) is a popular drug worldwide and use is prevalent in Aotearoa New Zealand. Although associated with some significant harms, including fatalities, MDMA is ultimately less harmful than other commonly consumed drugs. We aimed to expand the understanding of MDMA harm and harm reduction strategies from a consumer perspective so that national harm reduction efforts...

DOI: 10.1186/s12954-024-01024-8 (opens in new tab) Full text (opens in new tab) Aotearoa new zealand Harm reduction Reflexive thematic analysis Drug safety +3

Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand.

Harm Reduction Journal March 21, 2024 Jai Whelan, Geoff Noller, Ryan D Ward 6 citations

3,4-Methylenedioxymethamphetamine (MDMA) is drug of high prevalence in Aotearoa New Zealand and is the primary drug analysed by legal drug checking services. We aimed to address the gap in literature pertaining to MDMA-related harm reduction behaviour and harm experiences within the country. An online survey was used to assess the harm reduction behaviours (e.g., limiting consumption, planning...

Rolling through TikTok: An analysis of 3,4-methylenedioxymethamphetamine-related content.

Drug and Alcohol Review 2024 Jai Whelan, Geoffrey E Noller, Ryan D Ward

TikTok has quickly gained popularity through its platforming of large amounts of short video content. Given its widespread popularity, unrestricted access and poor content monitoring may allow 3,4-methylenedioxymethamphetamine (MDMA)-related content to influence perception of MDMA use. We aimed to investigate how MDMA-related videos are portrayed on TikTok and explore MDMA-related harm...

3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration

Drug Science, Policy and Law 2024 Jai Whelan, Geoff Noller, Ryan D Ward

The prevalence of 3,4-methylenedioxymethamphetamine (MDMA) consumption is relatively high in Aotearoa New Zealand, but MDMA use has not been investigated in detail. We explored consumption behaviours and a range of MDMA-related factors, including motivations, subjective effects, and reflections about personal MDMA use via a cross-sectional survey. A total of 1180 respondents (59.2% female, 15%...

Exploring the Promise of Ketamine Therapy for Autism: Benefits and Brain Changes

Journal of Clinical Research and Case Studies June 30, 2023 Ryan D Ward

Autism is a neurodevelopmental disorder that affects communication and social interaction abilities. While there are various therapeutic options available for autism, there is growing evidence suggesting that ketamine therapy could be a promising treatment for autism spectrum disorder (ASD). Ketamine is a dissociative anesthetic that has been used for decades in anesthesia and pain management,...